Skip to main content
Published locations for Metastatic CRC: Older females treated with FOLFOXIRI/bevacizumab at higher risk for neutropenia
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Metastatic CRC: Older females treated with FOLFOXIRI/bevacizumab at higher risk for neutropenia
User login
Username
Password
Reset your password
/content/metastatic-crc-older-females-treated-folfoxiri/bevacizumab-higher-risk-neutropenia
/hematology-oncology/article/248732/gi-oncology/metastatic-crc-older-females-treated-folfoxiri